elaborately designed a biomimetic nanovaccine capable of delivering cytokine, which consisted of membrane vesicles, obtained from genetically engineered DCs with IL‐15/IL‐15 receptor α expression, tumor‐associated antigenic and costimulatory molecules (Figure 4C). This evidence concerns the gene IL15 and neoplasm.